Providing high-quality HIV care in a deeply rural setting--the Zithulele experience.
Various aspects of the programme have evolved over time and have been modified, as we have learnt from our experiences, as the programme has expanded, and as the HIV climate has changed over the eight years since we started our first patient on highly active antiretroviral therapy (HAART) with the assistance of our neighbouring hospital. Specific aspects of our rural reality that have informed the innovations we have brought to the model of care include:
* Fragile clinics: There is high staff turnover, significant problems with procurement, an isolated work environment and lack of on-site clinical and systematic support. While staff receive training in clinical and policy implementation, this is often rote learning and ongoing mentorship is essential to bring depth of understanding. Zithulele staff provide strong links between the clinics and hospital, improving access to expertise and morale among clinic nurses.
* Mobile patients: Our large, still-growing number of patients are extremely mobile, with a lot of patient movement both between facilities within the programme borders, but also in and out of the geographical area due to migrant labour. A uniform system that works effectively across all sites and that is easy for patients to access from any programme facility has been critical to avoid confusion and to ensure continuity of care.
* Drug supply: In common with many other areas, our primary healthcare facilities have struggled to maintain continuous access to medication and other stock items. (Everything from paracetamol to antibiotics to ART for the prevention of mother-to-child transmission (PMTCT), as well as needles, HIV test kits and more, has been out of stock at some point over the years.) Not only is our district hospital committed to supporting primary healthcare, it is a resource-efficient and economically viable approach to link hospital and clinic care in order to prevent more complicated, expensive care at hospital level due to stock-outs at clinic level.
Preventing resistance in a context where drug regimens are limited and advanced treatment regimens may be difficult or impossible to access is critically important, both from a programmatic and individual patient perspective. More information on how we do this is included in the model presented below.
In light of these issues, we realised early on that while our programme requires an element of flexibility to meet the needs of a rural community, it also needs: to ensure that high quality, comprehensive care is accessible to all; to be stringent enough to promote adherence to lifelong treatment; and to provide an effective method of monitoring patients. We are privileged to have had access to resources that made it possible to avoid compromise on any of these aspects. Operating within a public sector context has also meant that any model that we implemented needed to meet national priorities and be flexible enough to adapt as these priorities change over time.
The HIV care model implemented across the Zithulele catchment area is outlined in Fig. 1. Programmes are always about more than just the numbers, but these indicators demonstrate how the model illustrated successfully provides high quality, accessible care:
* Large number of patients receiving treatment: as of end October 2013, 3 785 patients were receiving treatment, including 269 children; and over 5 000 patients have been initiated on antiretrovirals (ARVs) since 2005 (large numbers transfer out, often back to the mines)
* Ninety-one per cent of patients in the programme collect from their facility of choice: those patients who remain receiving care at the hospital are either those who require hospital-level intervention or those who choose, for reasons of their own, not to receive treatment at a clinic
* There is no waiting list to start ARVs at any facility, whether hospital or clinic, and patients can be initiated on treatment by doctors or nurses on any day of the week
* Excellent viral load (VL) protocol compliance: the results of a recent VL audit (a randomised review of half of the programme facilities) showed that in the past year, 92% of patients had a VL measurement performed on time--this is a significant achievement, especially considering the recently introduced changes in protocol
* A recent audit showed that 91% of our adult patients are still receiving first-line treatment and 94.5% of these have a suppressed VL (and 91% of all our active adult patients currently have a suppressed VL)
* No patient in the programme has ever been turned away without their full regimen of treatment--a momentous achievement in a district and province where ARV stock-outs have made regular headline news.
[FIGURE 1 OMITTED]
The government has focused on expanding programmes across the country, with energy and resources being directed towards ensuring access for all who need treatment. However, given the challenges outlined above and in line with our philosophy that rural care should not be second rate, we have emphasised the need for accessibility to quality care. The way we have designed and structured our programme, particularly our adoption of pre-packing medication from as soon as we started to provide decentralised, clinic-based care, has not always been well understood or received by middle managers who occasionally misinterpreted national policy as a one-size-fits-all directive. Nevertheless, the outcomes that have been achieved demonstrate that the long hours spent negotiating have been worthwhile.
As far as possible, we work within the existing structure and resources of the Eastern Cape Department of Health (ECDoH), but implementing the above programme does require some additional funding. Non-governmental organisation (NGO) support has made this possible, and in the current budgetary climate, continued NGO support remains essential to maintain this model. However, with the attention we are giving to strengthening and supporting the ECDoH systems and structures, and with an imminent expansion of government-funded prepacking, it is hoped that over time we will be able to maintain this standard of care without outside support.
Acknowledgements. Our thanks to the many staff who have worked with us over the years to design and implement this programme, including Drs Karl and Sally le Roux, Dr Taryn Gaunt, Dr Liz Gatley, Ms Monique Lines, staff of the Donald Woods Foundation and the Jabulani Rural Health Foundation. We also thank Cell-life who developed the iDART programme and the Vodacom Foundation who donated hardware and training.
S Afr J HIV Med 2014;15(1):28-29. DOI:10.7196/SAJHIVMED.1035
BA, BCom (Hons), MCom; MB ChB, MSc (PHC), DA, DipObst, DipHIVMan
Corresponding author: B Gaunt (email@example.com)
Catherine Young is affiliated with the Donald Woods Foundation, East London, South Africa. Benjamin Gaunt hails from Zithulele Hospital, Mqanduli, Eastern Cape Province, and is affiliated with the Eastern Cape Provincial Department of Health, South Africa.
|Printer friendly Cite/link Email Feedback|
|Author:||Young, C.; Gaunt, B.|
|Publication:||Southern African Journal of HIV Medicine|
|Date:||Mar 1, 2014|
|Previous Article:||Reflections on a decade of HIV in my life.|
|Next Article:||Reflections on a decade of delivering PMTCT in Khayelitsha, South Africa.|